Holen Sie sich die Stockscreener-App
8.20
0.99%
0.08
Cartesian Therapeutics Inc Aktie (RNAC) Neueste Nachrichten
Cartesian Therapeutics (NASDAQ:RNAC) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - Defense World
Why Cartesian Therapeutics Inc. stock is a value investor pickMarket Growth Summary & Reliable Price Action Trade Plans - ulpravda.ru
Cartesian Therapeutics (RNAC): Needham Raises Price Target to $4 - GuruFocus
Myasthenia Gravis Market Positioned for Accelerated - openPR.com
Cartesian Therapeutics highlights recent progress and outlines 2026 outlook - MarketScreener
Cartesian Therapeutics Reports Progress in Phase 3 AURORA Trial of Descartes-08 for Myasthenia Gravis and Initiates Pediatric Trial for Juvenile Dermatomyositis - Quiver Quantitative
Cartesian Therapeutics Highlights 2026 Strategic Priorities - TradingView — Track All Markets
Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook - GlobeNewswire
Cell therapy shows immune 'reset' potential in severe muscle disease - Stock Titan
What momentum indicators show for Cartesian Therapeutics Inc. stockQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Is Cartesian Therapeutics Inc. stock resilient to inflationJuly 2025 Final Week & Growth Focused Stock Pick Reports - ulpravda.ru
Is Cartesian Therapeutics Inc. stock supported by innovation pipelineWeekly Stock Report & Free Technical Pattern Based Buy Signals - ulpravda.ru
Is Cartesian Therapeutics Inc. stock a buy before product launches2026 world cup usa national team quarterfinals defensive leaders transition play group prediction preview - ulpravda.ru
Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment - Benzinga
Cartesian Therapeutics, Inc.Common Stock (NQ: RNAC - FinancialContent
Cartesian Therapeutics Announces New Employment Inducement Grants - The Manila Times
Biotech offering cell therapies uses stock options to lure new talent - Stock Titan
What analysts say about Cartesian Therapeutics Inc 1S70 stockPortfolio Allocation Tips & Small Investment Wealth Growth - earlytimes.in
Contrasting Beyond Air (NASDAQ:XAIR) & Cartesian Therapeutics (NASDAQ:RNAC) - Defense World
Working capital per share of Cartesian Therapeutics, Inc. – BER:1S70 - TradingView — Track All Markets
Does Cartesian Therapeutics Inc. stock trade at a discount to peersChart Signals & Daily Volume Surge Signals - Улправда
Cartesian Therapeutics Earnings Notes - Trefis
What catalysts could drive Cartesian Therapeutics Inc. stock higherChart Signals & Daily Volume Surge Signals - Улправда
Aug Wrap: Why Cartesian Therapeutics Inc. (1S70) stock could be top winnerWeekly Gains Summary & Daily Volume Surge Trade Alerts - DonanımHaber
Can Cartesian Therapeutics Inc. stock maintain growth trajectoryQuarterly Market Review & AI Driven Stock Movement Reports - DonanımHaber
Earnings Recap: How Cartesian Therapeutics Inc. stock trades during market volatilityJuly 2025 Chart Watch & Reliable Breakout Forecasts - DonanımHaber
Cartesian Therapeutics Appoints Adrian Bot to Board of Directors - citybiz
How Cartesian Therapeutics Inc. stock performs in interest rate cyclesDay Trade & Expert Curated Trade Ideas - Улправда
Cartesian Therapeutics, Inc.(NasdaqGM:RNAC) dropped from NASDAQ Biotechnology Index - marketscreener.com
Is Cartesian Therapeutics Inc. stock in correction or buying zoneMarket Activity Report & Community Trade Idea Sharing - Улправда
Cartesian Therapeutics Appoints Dr. Adrian Bot to Board of Directors - Quiver Quantitative
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors - The Manila Times
Will Cartesian Therapeutics Inc. stock deliver better than expected guidanceJuly 2025 Technicals & Low Risk Growth Stock Ideas - Улправда
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
683 Capital Management LLC Grows Stock Holdings in Cartesian Therapeutics, Inc. $RNAC - Defense World
Cartesian rebounds after insider purchase - MSN
Independent Director of Cartesian Therapeutics Picks Up 168% More Stock - simplywall.st
Cartesian Therapeutics (RNAC) Sees Share Boost After Insider Pur - GuruFocus
Cartesian stock rebounds after insider buy (RNAC:NASDAQ) - Seeking Alpha
Cartesian Therapeutics Director Purchases 30,000 Shares - TradingView — Track All Markets
Can Cartesian Therapeutics Stock Recover If Markets Fall? - Trefis
Here's Why We're Watching Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Situation - Yahoo Finance
What MACD trends signal for Cartesian Therapeutics Inc. (1S70) stockPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
Why Cartesian Therapeutics Inc. (1S70) stock stays undervaluedJuly 2025 Price Swings & Verified Momentum Stock Alerts - Newser
Weekly Earnings: What is the fair value estimate for Cartesian Therapeutics Inc 1S70 stock in 20252025 AllTime Highs & Reliable Volume Spike Trade Alerts - BỘ NỘI VỤ
What is the fair value estimate for Cartesian Therapeutics Inc. (1S70) stock in 2025Bond Market & Verified Momentum Stock Watchlist - Newser
Is Cartesian Therapeutics Inc. (1S70) stock a buy for dividend portfoliosEarnings Trend Report & Weekly Stock Breakout Alerts - Newser
Is Cartesian Therapeutics Inc. stock cheap at current valuationEarnings Growth Report & Real-Time Volume Analysis - Newser
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):